Oleoylethanolamide, an endogenous PPAR-α agonist, lowers body weight and hyperlipidemia in obese rats

Neuropharmacology

Volumn 48, Issue 8 SPEC. ISS., 2005, Pages 1147-1153

  Fu, Jin ^a   Oveisi, Fariba ^a   Gaetani, Silvana ^b   Lin, Edward ^a   Piomelli, Daniele ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Lipid metabolism; Obesity; Oleoylethanolamine (OEA); Peroxisome proliferator activated receptor alpha (PPAR ); Zucker rat

Indexed keywords

CARRIER PROTEIN; FATTY ACID BINDING PROTEIN; LEPTIN RECEPTOR; LIPID; N OLEOYLETHANOLAMINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONIST; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FOOD INTAKE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HYPERLIPIDEMIA; LIPID METABOLISM; LIVER CELL; MALE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STAINING; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 19444372260     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2005.02.013     Document Type: Article

References (17)

1. J. Berger, and D.E. Moller The mechanisms of action of PPARs Annu. Rev. Med. 53 2002 409 435
2. V. Bocher, G. Chinetti, J.C. Fruchart, and B. Staels Role of the peroxisome proliferator-activated receptors (PPARs) in the regulation of lipids and inflammation control J. Soc. Biol. 196 2002 47 52
3. G.A. Bray The Zucker-fatty rat: a review Fed. Proc. 36 1977 148 153
4. P.J. Brown, J.M. Chapman, J.A. Oplinger, L.W. Stuart, T.M. Willson, and Z. Wu Chemical compounds as selective activators of PPAR-α PCT Int. Appl. 2000 32
5. A.Y. Chang, B.M. Wyse, B.J. Gilchrist, T. Peterson, and A.R. Diani Ciglitazone, a new hypoglycemic agent. I. Studies in ob/ob and db/db mice, diabetic Chinese hamsters, and normal and streptozotocin-diabetic rats Diabetes 32 1983 830 838
6. B. Desvergne, and W. Wahli Peroxisome proliferator-activated receptors: nuclear control of metabolism Endocr. Rev. 20 1999 649 688
7. J. Fu, S. Gaetani, F. Oveisi, J. Lo Verme, A. Serrano, F. Rodriguez De Fonseca, A. Rosengarth, H. Luecke, B. Di Giacomo, G. Tarzia, and D. Piomelli Oleoylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-α Nature 425 2003 90 93
8. S. Gaetani, F. Oveisi, and D. Piomelli Modulation of meal pattern in the rat by the anorexic lipid mediator oleoylethanolamide Neuropsycopharmacology 28 2003 1311 1316
9. F.M. Gregoire, Q. Zhang, S.J. Smith, C. Tong, D. Ross, H. Lopez, and D.B. West Diet-induced obesity and hepatic gene expression alterations in C57BL/6J and ICAM-1-deficient mice Am. J. Physiol. Endocrinol. Metab. 282 2002 E703 E713
10. M. Guzmán, J. Lo Verme, J. Fu, F. Oveisi, C. Blazquez, and D. Piomelli Oleoylethanolamide stimulates lipolysis by activating the nuclear receptor peroxisome proliferator-activated receptor-α (PPAR-α) J. Biol. Chem. 279 2004 27849 27854
11. R. Koopman, G. Schaat, and M. Hesselink Optimisation of Oil red O staining permits combination with immunofluorescence and automated quantification of lipids Histochem. Cell. Biol. 116 2001 63 68
12. S.S. Lee, T. Pineau, J. Drago, E.J. Lee, J.W. Owens, D.L. Kroetz, P.M. Fernández-Salguero, H. Westphal, and F.J. Gonzalez Targeted disruption of the α isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators Mol. Cell. Biol. 15 1995 3012 3022
13. C. Meunier-Durmort, H. Poirier, I. Niot, C. Forest, and P. Besnard Up-regulation of the expression of the gene for liver fatty acid-binding protein by long-chain fatty acids Biochem. J. 319 1996 483 487
14. W.R. Oliver Jr., J.L. Shenk, M.R. Snaith, C.S. Russell, K.D. Plunket, N.L. Bodkin, M.C. Lewis, D.A. Winegar, M.L. Sznaidman, M.H. Lambert, H.E. Xu, D.D. Sternbach, S.A. Kliewer, B.C. Hansen, and T.M. Willson A selective peroxisome proliferator-activated receptor δ agonist promotes reverse cholesterol transport Proc. Natl Acad. Sci. U.S.A. 98 2001 5306 5311
15. F. Rodríguez de Fonseca, M. Navarro, R. Gómez, L. Escuredo, F. Nava, J. Fu, E. Murillo-Rodríguez, A. Giuffrida, J. LoVerme, S. Gaetani, S. Kathuria, C. Gall, and D. Piomelli An anorexic lipid mediator regulated by feeding Nature 414 2001 209 212
16. T.D. Schmittgen, B.A. Zakrajsek, A.G. Mills, V. Gorn, M.J. Singer, and M.W. Reed Quantitative reverse transcription-polymerase chain reaction to study mRNA decay: comparison of endpoint and real-time methods Anal. Biochem. 285 2000 194 204
17. T.M. Willson, P.J. Brown, D.D. Sternbach, and B.R. Henke The PPARs: from orphan receptors to drug discovery J. Med. Chem. 43 2000 527 550